Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Receptors, Dopamine D2 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D1 < Receptors, Dopamine D2 < Receptors, Dopamine D3  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D2

Number of relevant bibliographic references: 69.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
003D37 (2004) Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne]Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting “sleep attacks”
003E09 (2004) Sebastian Paus [Allemagne] ; Gert Seeger [Allemagne] ; Hans M. Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Mahha El-Faddagh [Allemagne] ; Markus M. Nöthen [Belgique] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease
003E30 (2004) Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
003F37 (2003) Klaus L. Leenders [Pays-Bas]Significance of non‐presynaptic SPECT tracer methods in Parkinson's disease
003F46 (2003) Kirn R. Kessler [Allemagne] ; Gilbert Wunderlich [Allemagne] ; Harald Hefter [Allemagne] ; Rüdiger J. Seitz [Allemagne]Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density
004122 (2003) Eng-King Tan [Singapour] ; Yanni Tan [Singapour] ; Anthea Chai [Singapour] ; Christopher Tan [Singapour] ; Hui Shen [Singapour] ; Sau-Ying Lum [Singapour] ; Stephanie M. C. Fook-Cheong [Singapour] ; Mei-Ling Teoh [Singapour] ; Yuan Yih [Singapour] ; Meng-Cheong Wong [Singapour] ; Yi Zhao [Singapour]Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
004284 (2002) Guy Arnold [Allemagne] ; Klaus Tatsch [Allemagne] ; Eduardo Kraft [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes Schwarz [Allemagne]Steele‐Richardson‐Olszewski‐Syndrome: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI study
004381 (2002) Mehran Ghaemi [Allemagne] ; Jan Raethjen [Allemagne] ; Rüdiger Hilker [Allemagne] ; Jobst Rudolf [Allemagne] ; Jan Sobesky [Allemagne] ; Günther Deuschl [Allemagne] ; Wolf-Dieter Heiss [Allemagne]Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study
004532 (2002) Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
004664 (2001) J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis]Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study
004722 (2001) Virgilio Gerald H. Evidente [Philippines]Piribedil for restless legs syndrome: A pilot study
004776 (2001) D. A. Grimes [Canada] ; D. Bulman [Canada] ; P. St. George-Hyslop [Canada] ; A. E. Lang [Canada]Inherited myoclonus‐dystonia: Evidence supporting genetic heterogeneity
004825 (2001) Mario Zappia [Italie] ; Grazia Annesi [Italie] ; Aldo Quattrone [Italie]Dopamine D2 receptor TaqI A polymorphism and Parkinson's disease
004948 (2000) Rosario L. Oliveri [Italie] ; Grazia Annesi [Italie] ; Mario Zappia [Italie] ; Donatella Civitelli [Italie] ; Elvira V. De Marco [Italie] ; Angela A. Pasqua [Italie] ; Ferdinanda Annesi [Italie] ; Patrizia Spadafora [Italie] ; Antonio Gambardella [Italie] ; Giuseppe Nicoletti [Italie] ; Damiano Branca [Italie] ; Manuela Caracciolo [Italie] ; Umberto Aguglia [Italie] ; Aldo Quattrone [Italie]The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease
004A04 (2000) Paul R. Jarman [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Charles Davie [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; Simon D. Taylor-Robinson [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni]Paroxysmal dystonic choreoathetosis: Clinical features and investigation of pathophysiology in a large family
004A78 (2000) Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Endogenous dopaminergic tone and dopamine agonist action
004B53 (2000) L. Grevle [Norvège] ; C. Güzey [Norvège] ; H. Hadidi [Norvège] ; R. Brennersted [Norvège] ; J. R. Idle [Norvège] ; J. Aasly [Norvège]Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease
004C17 (1999) Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
004C34 (1999) Christine Dentresangle [France] ; Laurent Veyre [France] ; Didier Le Bars [France] ; Christian Pierre [France] ; Frank Lavenne [France] ; Pierre Pollak [France] ; Jeanine Guerin [France] ; Jean-Claude Froment [France] ; Emmanuel Brousolle [France]Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study
004D22 (1999) David C. C. Wan [Hong Kong] ; L. K. Law [Hong Kong] ; Denis T. M. Ip [Hong Kong] ; W. T. Cheung [Hong Kong] ; Walter K. K. Ho [Hong Kong] ; Karl W. K. Tsim [Hong Kong] ; R. Kay [Hong Kong] ; J. Woo [Hong Kong] ; C. P. Pang [Hong Kong]Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a chinese population
004F42 (1998) Vincent P. Calabrese [États-Unis] ; K. Alvin Lloyd [États-Unis] ; Pasquale Brancazio [États-Unis] ; Eugene Cefali [États-Unis] ; Pauline Martin [États-Unis] ; James Wall Jr. [États-Unis] ; Dominic Sica [États-Unis]N‐0923, A novel soluble dopamine D2 agonist in the treatment of parkinsonism

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Receptors, Dopamine D2" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Receptors, Dopamine D2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Receptors, Dopamine D2
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024